S. Vural Et Al. , "Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report," Indian Journal of Otolaryngology and Head and Neck Surgery , vol.1, no.1, pp.1-2, 2022
Vural, S. Et Al. 2022. Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report. Indian Journal of Otolaryngology and Head and Neck Surgery , vol.1, no.1 , 1-2.
Vural, S., Kuşdoğan, M., Kaya, H. B., İkiz, V., & Albayrak, L., (2022). Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report. Indian Journal of Otolaryngology and Head and Neck Surgery , vol.1, no.1, 1-2.
Vural, SEVİLAY Et Al. "Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report," Indian Journal of Otolaryngology and Head and Neck Surgery , vol.1, no.1, 1-2, 2022
Vural, SEVİLAY Et Al. "Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report." Indian Journal of Otolaryngology and Head and Neck Surgery , vol.1, no.1, pp.1-2, 2022
Vural, S. Et Al. (2022) . "Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report." Indian Journal of Otolaryngology and Head and Neck Surgery , vol.1, no.1, pp.1-2.
@article{article, author={SEVİLAY VURAL Et Al. }, title={Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report}, journal={Indian Journal of Otolaryngology and Head and Neck Surgery}, year=2022, pages={1-2} }